Dr. Jonathan A. Rapp, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Ohio State University College of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 579
Licensed in Illinois since 2006, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Ohio State University College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
OH license 35.097373 · LA license MD.202721 -
Internal Medicine Physician
IL license 036115898 (first issued 2006; not renewed)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Bethesda North Cincinnati, OH
- Christ Hospital Cincinnati, OH
- Good Samaritan Hospital Cincinnati, OH
- Mccullough-Hyde Memorial Hospital Oxford, OH
Medical groups
- Trihealth H LLC (850 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 579
- Services billed
- 1,751
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 300 | 203 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 148 | 133 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | 97 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 97 | 93 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 83 | 48 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 59 | 59 |
| Established patient office or other outpatient visit, 40-54 minutes | 52 | 44 |
| Ultrasound of heart, follow-up | 45 | 39 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 40 | 36 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 40 | 36 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 48 payments worth $3,413 in total to this clinician.
| Abbott Laboratories | $2,034 |
|---|---|
| Aop Health US, LLC | $424 |
| Edwards Lifesciences Corporation | $274 |
| Medtronic, Inc. | $180 |
| Heartflow, Inc. | $144 |
| Novartis Pharmaceuticals Corporation | $108 |
| AstraZeneca Pharmaceuticals LP | $58.71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $54.69 |
| Food and Beverage | $2,261 |
|---|---|
| Travel and Lodging | $1,152 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Jan 30, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Austin, TX · in-kind | $615 |
| Abbott Laboratories Jan 30, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Austin, TX · in-kind | $340 |
| Abbott Laboratories Mar 21, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Austin, TX · in-kind | $44.00 |
| Abbott Laboratories Mar 21, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Austin, TX · in-kind | $40.11 |
| Abbott Laboratories Jan 25, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Austin, TX · in-kind | $38.83 |
| Abbott Laboratories Jan 25, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Austin, TX · in-kind | $35.06 |
| Abbott Laboratories Mar 21, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Austin, TX · in-kind | $30.07 |
| Abbott Laboratories Jan 30, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Austin, TX · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $21,785 in research payments for these studies, mostly to the institutions running them.
- CLASP II TR Pivotal, Study No. 2019-07
Edwards Lifesciences Corporation - SMART Trial
Medtronic, Inc. - NCT03309332--AMPLATZER PFO Occluder Post Approval Study
Abbott Laboratories - TAVR Low Risk
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.